comparemela.com

Latest Breaking News On - Pivotal study - Page 1 : comparemela.com

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation

United statesNew yorkJacob javits convention centerDrug administrationJacobk javits convention centerPopulation health scienceJournal of the american college cardiologyTrans septal mitral valve replacementMitral regurgitationInvestigational device exemptionPivotal studyFunctional mitral regurgitationAmerican collegeAcademic affairsMount sinai health systemIcahn school

PolarityTE Raises $22 5M Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Salt lake cityUnited statesJohn stetsonCapital groupDrug administrationVenture opportunities fundAvenue venture opportunities fundVenture debtAvenue capitalPivotal studyFoot ulcers

Lipocine : Announces First Cohort Dosed in Pivotal Study of LPCN 1154 - Form 8-K -March 25, 2024 at 06:17 am EDT

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154 Company anticipates topline results from this crossover pivotal study late in the second quarter of 2024 .

United statesMahesh patelKrista fogartyTruist securities researchLipocine incDrug administrationLipocine announces first cohort dosedPivotal studyCentral nervous systemNew drug applicationPostpartum depressionUnmet needsPrivate securities litigation reform act

Nuwellis Distribution Partner, SeaStar Medical, Receives

MINNEAPOLIS, Feb. 22, 2024 (GLOBE NEWSWIRE) Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people.

Dunia cristanAquadex smartflowNestor jaramillo jrEric schlorffVivian cervantesOffice of orphan products developmentSeastar medical holding corporation nasdaqNuwellis incDrug administrationSeastar medical holding corporationGilmartin groupStar medical holding corporationSeastar medicalHumanitarian device exemptionSelective cytophereticNestor jaramillo

Surgical Adhesion Barriers Pipeline Report 2023, including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

/PRNewswire/ The "Surgical Adhesion Barriers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key.

United arab emiratesNew jerseyUnited statesLaura woodFziomed incSurgical adhesion barriers companiesMagen orthomed ltdGenzyme corpPipeline products under developmentE st office hours callAnika therapeutics incDalim tissen co ltdKey companiesStage of developmentSporogenics pte ltdDevices inc

vimarsana © 2020. All Rights Reserved.